Innate Pharma (IPHA) Institutional Ownership → Write this ticker symbol down… (From StocksToTrade) (Ad) Free IPHA Stock Alerts $2.89 +0.23 (+8.65%) (As of 06/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Innate Pharma (NASDAQ:IPHA)CurrentInstitutional OwnershipPercentage0.16%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$438.08KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$925.42K Get IPHA Insider Trade Alerts Want to know when executives and insiders are buying or selling Innate Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPHA Institutional Buying and Selling by Quarter Ad Weiss Ratings[URGENT] DO NOT Touch These AI Stocks!Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond Innate Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Optiver Holding B.V.22,705$64K0.0%-88.1%0.028% 1/5/2024 Exchange Traded Concepts LLC46,888$131K0.0%+34.0%0.058% 11/13/2023 Optiver Holding B.V.190,219$481K0.0%+132.6%0.236% 10/18/2023 Exchange Traded Concepts LLC34,998$89K0.0%-17.5%0.043% 8/10/2023 Optiver Holding B.V.81,796$257K0.0%-63.5%0.102% 7/20/2023 Exchange Traded Concepts LLC42,431$133K0.0%N/A0.053% 5/11/2023 Optiver Holding B.V.224,097$636K0.0%+112.3%0.279% 2/14/2023Susquehanna International Group LLP13,315$50K0.0%N/A0.017% 2/10/2023 Optiver Holding B.V.105,534$394K0.0%-43.1%0.132% 8/10/2022 Optiver Holding B.V.181,944$491K0.0%+366.8%0.228% 2/9/2022 Alps Advisors Inc.93,718$429K0.0%N/A0.118% 12/1/2021 Balyasny Asset Management LLC187,484$1.16M0.0%N/A0.236% 11/16/2021 Two Sigma Securities LLC17,119$106K0.0%N/A0.022% 11/15/2021 Pura Vida Investments LLC82,509$509K0.0%N/A0.104% 11/15/2021 Balyasny Asset Management LLC187,484$1.16M0.0%N/A0.236% 11/12/2021 Affinity Asset Advisors LLC125,000$771K0.2%N/A0.158% 5/21/2021 Citadel Advisors LLC25,250$109K0.0%N/A0.032% 5/20/2021 Optiver Holding B.V.30,284$131K0.0%N/A0.038% 5/18/2021 Millennium Management LLC49,734$214K0.0%-9.1%0.063% 5/18/2021 Citadel Advisors LLC25,250$109K0.0%N/A0.032% 5/14/2021 Optiver Holding B.V.55,588$240K0.0%N/A0.070% 5/14/2020 Wellington Management Group LLP1,334,110$8.91M0.0%-1.5%1.743% (Data available from 1/1/2016 forward) IPHA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPHA shares? During the previous two years, the following institutional investors and hedge funds held shares of Innate Pharma shares: Exchange Traded Concepts LLC ($131K), and Optiver Holding B.V. ($64K), Susquehanna International Group LLP ($50K).Learn more on IPHA's institutional investors. What percentage of Innate Pharma stock is owned by institutional investors? 0.16% of Innate Pharma stock is owned by institutional investors. Learn more on IPHA's institutional investor holdings. Which institutional investors have been buying Innate Pharma stock? The following institutional investors have purchased Innate Pharma stock in the last 24 months: Optiver Holding B.V. ($369.96K), Exchange Traded Concepts LLC ($54.32K), and Susquehanna International Group LLP ($13.32K). How much institutional buying is happening at Innate Pharma? Institutional investors have bought a total of 437,592 shares in the last 24 months. This purchase volume represents approximately $1.21M in transactions. Which Innate Pharma major shareholders have been selling company stock? The following institutional investors have sold Innate Pharma stock in the last 24 months: Optiver Holding B.V. ($389.59K), and Exchange Traded Concepts LLC ($7.43K). How much institutional selling is happening at Innate Pharma? Institutional investors have sold a total of 397,024 shares in the last 24 months. This volume of shares sold represents approximately $1.22M in transactions. Related Companies: INBX Major Shareholders MESO Major Shareholders HUMA Major Shareholders SRRK Major Shareholders PRME Major Shareholders CRGX Major Shareholders PROK Major Shareholders RGNX Major Shareholders EXAI Major Shareholders TSHA Major Shareholders This page (NASDAQ:IPHA) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.